by James Nurton | Jan 31, 2023 | Uncategorized
Interviewed on the flagship BBC radio programme Today in November last year, AstraZeneca chief executive Pascal Soriot launched a strong defence of the pharmaceutical industry and in particular the role of IP rights in incentivising research into new drugs. He was...
